vs
Side-by-side financial comparison of Flywire Corp (FLYW) and AMICUS THERAPEUTICS, INC. (FOLD). Click either name above to swap in a different company.
AMICUS THERAPEUTICS, INC. is the larger business by last-quarter revenue ($185.2M vs $157.5M, roughly 1.2× Flywire Corp). AMICUS THERAPEUTICS, INC. runs the higher net margin — 0.9% vs 0.0%, a 0.9% gap on every dollar of revenue. On growth, Flywire Corp posted the faster year-over-year revenue change (34.0% vs 23.7%). AMICUS THERAPEUTICS, INC. produced more free cash flow last quarter ($16.0M vs $4.5M). Over the past eight quarters, AMICUS THERAPEUTICS, INC.'s revenue compounded faster (29.5% CAGR vs 17.5%).
Flywire Corp is a global payment and receivables solutions provider serving core verticals including education, healthcare, travel, and B2B commerce. It offers secure cross-border payment processing, currency conversion, and workflow tools for organizations and payers worldwide.
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
FLYW vs FOLD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $157.5M | $185.2M |
| Net Profit | $33.0K | $1.7M |
| Gross Margin | — | 85.7% |
| Operating Margin | -0.6% | 8.6% |
| Net Margin | 0.0% | 0.9% |
| Revenue YoY | 34.0% | 23.7% |
| Net Profit YoY | 100.2% | -88.5% |
| EPS (diluted) | $0.01 | $0.00 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $157.5M | $185.2M | ||
| Q3 25 | $200.1M | $169.1M | ||
| Q2 25 | $131.9M | $154.7M | ||
| Q1 25 | $133.5M | $125.2M | ||
| Q4 24 | $117.5M | $149.7M | ||
| Q3 24 | $156.8M | $141.5M | ||
| Q2 24 | $103.7M | $126.7M | ||
| Q1 24 | $114.1M | $110.4M |
| Q4 25 | $33.0K | $1.7M | ||
| Q3 25 | $29.6M | $17.3M | ||
| Q2 25 | $-12.0M | $-24.4M | ||
| Q1 25 | $-4.2M | $-21.7M | ||
| Q4 24 | $-15.9M | $14.7M | ||
| Q3 24 | $38.9M | $-6.7M | ||
| Q2 24 | $-13.9M | $-15.7M | ||
| Q1 24 | $-6.2M | $-48.4M |
| Q4 25 | — | 85.7% | ||
| Q3 25 | — | 88.5% | ||
| Q2 25 | — | 90.2% | ||
| Q1 25 | — | 90.7% | ||
| Q4 24 | — | 90.1% | ||
| Q3 24 | — | 90.6% | ||
| Q2 24 | — | 91.1% | ||
| Q1 24 | — | 87.7% |
| Q4 25 | -0.6% | 8.6% | ||
| Q3 25 | 16.1% | 20.3% | ||
| Q2 25 | -6.8% | -6.1% | ||
| Q1 25 | -8.2% | -6.3% | ||
| Q4 24 | -4.9% | 10.7% | ||
| Q3 24 | 12.9% | 15.3% | ||
| Q2 24 | -15.2% | 11.8% | ||
| Q1 24 | -5.2% | -25.1% |
| Q4 25 | 0.0% | 0.9% | ||
| Q3 25 | 14.8% | 10.2% | ||
| Q2 25 | -9.1% | -15.8% | ||
| Q1 25 | -3.1% | -17.3% | ||
| Q4 24 | -13.5% | 9.8% | ||
| Q3 24 | 24.8% | -4.8% | ||
| Q2 24 | -13.4% | -12.4% | ||
| Q1 24 | -5.4% | -43.9% |
| Q4 25 | $0.01 | $0.00 | ||
| Q3 25 | $0.23 | $0.06 | ||
| Q2 25 | $-0.10 | $-0.08 | ||
| Q1 25 | $-0.03 | $-0.07 | ||
| Q4 24 | $-0.12 | $0.05 | ||
| Q3 24 | $0.30 | $-0.02 | ||
| Q2 24 | $-0.11 | $-0.05 | ||
| Q1 24 | $-0.05 | $-0.16 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $355.0M | $293.5M |
| Total DebtLower is stronger | — | $392.7M |
| Stockholders' EquityBook value | $835.2M | $274.2M |
| Total Assets | $1.3B | $949.9M |
| Debt / EquityLower = less leverage | — | 1.43× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $355.0M | $293.5M | ||
| Q3 25 | $377.3M | $263.8M | ||
| Q2 25 | $274.2M | $231.0M | ||
| Q1 25 | $255.3M | $250.6M | ||
| Q4 24 | $611.1M | $249.9M | ||
| Q3 24 | $681.1M | $249.8M | ||
| Q2 24 | $571.0M | $260.1M | ||
| Q1 24 | $619.0M | $239.6M |
| Q4 25 | — | $392.7M | ||
| Q3 25 | $15.0M | $392.0M | ||
| Q2 25 | $60.0M | $391.3M | ||
| Q1 25 | $60.0M | $390.7M | ||
| Q4 24 | $0 | $390.1M | ||
| Q3 24 | — | $389.5M | ||
| Q2 24 | — | $388.9M | ||
| Q1 24 | — | $388.4M |
| Q4 25 | $835.2M | $274.2M | ||
| Q3 25 | $829.1M | $230.4M | ||
| Q2 25 | $792.4M | $204.3M | ||
| Q1 25 | $784.3M | $193.6M | ||
| Q4 24 | $814.8M | $194.0M | ||
| Q3 24 | $843.2M | $178.8M | ||
| Q2 24 | $802.6M | $132.5M | ||
| Q1 24 | $-797.0M | $130.7M |
| Q4 25 | $1.3B | $949.9M | ||
| Q3 25 | $1.3B | $868.8M | ||
| Q2 25 | $1.1B | $815.3M | ||
| Q1 25 | $1.1B | $789.8M | ||
| Q4 24 | $1.1B | $785.0M | ||
| Q3 24 | $1.2B | $786.6M | ||
| Q2 24 | $998.7M | $749.5M | ||
| Q1 24 | $998.7M | $721.8M |
| Q4 25 | — | 1.43× | ||
| Q3 25 | 0.02× | 1.70× | ||
| Q2 25 | 0.08× | 1.92× | ||
| Q1 25 | 0.08× | 2.02× | ||
| Q4 24 | 0.00× | 2.01× | ||
| Q3 24 | — | 2.18× | ||
| Q2 24 | — | 2.93× | ||
| Q1 24 | — | 2.97× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $4.9M | $16.3M |
| Free Cash FlowOCF − Capex | $4.5M | $16.0M |
| FCF MarginFCF / Revenue | 2.9% | 8.6% |
| Capex IntensityCapex / Revenue | 0.2% | 0.2% |
| Cash ConversionOCF / Net Profit | 148.06× | 9.62× |
| TTM Free Cash FlowTrailing 4 quarters | $98.8M | $29.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.9M | $16.3M | ||
| Q3 25 | $150.1M | $35.7M | ||
| Q2 25 | $24.1M | $-26.5M | ||
| Q1 25 | $-78.9M | $7.8M | ||
| Q4 24 | $-28.6M | $-3.9M | ||
| Q3 24 | $184.6M | $-23.0M | ||
| Q2 24 | $-19.3M | $22.7M | ||
| Q1 24 | $-38.1M | $-29.7M |
| Q4 25 | $4.5M | $16.0M | ||
| Q3 25 | $149.9M | $35.3M | ||
| Q2 25 | $23.5M | $-28.9M | ||
| Q1 25 | $-79.1M | $7.5M | ||
| Q4 24 | $-28.7M | $-4.2M | ||
| Q3 24 | $184.4M | $-23.3M | ||
| Q2 24 | $-19.7M | $21.6M | ||
| Q1 24 | $-38.3M | $-31.5M |
| Q4 25 | 2.9% | 8.6% | ||
| Q3 25 | 74.9% | 20.9% | ||
| Q2 25 | 17.8% | -18.7% | ||
| Q1 25 | -59.3% | 6.0% | ||
| Q4 24 | -24.4% | -2.8% | ||
| Q3 24 | 117.6% | -16.5% | ||
| Q2 24 | -19.0% | 17.0% | ||
| Q1 24 | -33.6% | -28.5% |
| Q4 25 | 0.2% | 0.2% | ||
| Q3 25 | 0.1% | 0.2% | ||
| Q2 25 | 0.4% | 1.6% | ||
| Q1 25 | 0.1% | 0.2% | ||
| Q4 24 | 0.1% | 0.2% | ||
| Q3 24 | 0.1% | 0.3% | ||
| Q2 24 | 0.3% | 0.9% | ||
| Q1 24 | 0.2% | 1.6% |
| Q4 25 | 148.06× | 9.62× | ||
| Q3 25 | 5.07× | 2.06× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -0.27× | ||
| Q3 24 | 4.75× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FLYW
| Transactions | $126.4M | 80% |
| Platform And Other Revenues | $31.1M | 20% |
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
